The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Abstract
The obesity epidemic is closely associated with the rising prevalence and severity of nonalcoholic fatty liver disease (NAFLD): obesity has been linked not only with simple steatosis (SS), but also with advanced disease, i.e., nonalcoholic steatohepatitis (NASH), NASH-related cirrhosis and hepatocellular carcinoma. As a consequence, apart from increasing all-cause mortality, obesity seems to increase liver-specific mortality in NAFLD patients. Given the lack of approved pharmacological interventions for NAFLD, targeting obesity is a rational option for its management. As the first step, lifestyle modification (diet and exercise) is recommended, although it is difficult to achieve and sustain. When the first step fails, adding pharmacotherapy is recommended. Several anti-obesity medications have been investigated in NAFLD (e.g., orlistat, glucagon-like peptide-1 analogs), other anti-obesity medications have not been investigated (e.g., lorcaserin, phentermine hydrochloric, phentermine/topiramate and naltrexone/bupropion), whereas some medications with weight-lowering efficacy have not been approved for obesity (e.g., sodium-glucose cotransporter-2 inhibitors, farnesoid X receptor ligands). If the combination of lifestyle modification and pharmacotherapy also fails, then bariatric surgery should be considered in selected morbidly obese individuals. This review summarizes best evidence linking obesity with NAFLD and presents related therapeutic options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Li, B., Wang, Y., Ye, Z., Yang, H., Cui, X., Wang, Z., & Liu, L. (2018) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps29831 · Cited by 46
Effect of intragastric balloons on liver enzymes: A systematic review and meta-analysis
Popov, V. B., Thompson, C. C., Kumar, N., Ciarleglio, M. M., Deng, Y., & Laine, L. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4178-2 · Cited by 43
Feijó, S. G., Lima, J. M. D. C., Serra, M. A. A. D. O., Patrocínio, R. M. D. S. V., Moura-Junior, L. G., Campos, A. B., Lima, J. W. O., & Braga, L. L. B. C. (2013) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502013001100008 · Cited by 39
van den Berg, E. H., Douwes, R. M., de Meijer, V. E., Schreuder, T. C. M. A., & Blokzijl, H. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.08.022 · Cited by 39
Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances
Cruz-Ramón, V., Chinchilla-López, P., Ramírez-Pérez, O., & Méndez‐Sánchez, N. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5498 · Cited by 38
Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis
Njei, B. M., McCarty, T. R., Sharma, P., Lange, A., Najafian, N., Ngu, J. N., Ngomba, V., & Echouffo-Tcheugui, J. B. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3431-5 · Cited by 36
Boden, G. H. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.019 · Cited by 31
Safety and efficacy of bariatric surgery in patients with advanced fibrosis
Singh, T., Kochhar, G. S., Goh, G. B., Schauer, P. R., Brethauer, S. A., Kroh, M., Aminian, A., López, R., Dasarathy, S., & McCullough, A. J. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.212 · Cited by 31
Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
Koukias, N., Buzzetti, E., & Tsochatzis, E. A. (2017) · Minerva Endocrinology · doi:10.23736/s0391-1977.16.02567-0 · Cited by 31
Nonalcoholic fatty liver disease
Pοlyzos, S. A., Kountouras, J., Anastasiadis, S., Doulberis, M., & Katsinelos, P. (2018) · Hepatology · doi:10.1002/hep.29897 · Cited by 31
Self-citationWu, J., Xu, H., He, X., Yuan, Y., Wang, C., Sun, J., He, S., & Niu, J. (2017) · Scientific Reports · doi:10.1038/srep41518 · Cited by 30
Świderska, M., Jaroszewicz, J., Stawicka, A., Parfieniuk‐Kowerda, A., Chabowski, A., & Flisiak, R. (2017) · Clinical and Experimental Hepatology · doi:10.5114/ceh.2017.68466 · Cited by 28
Vonghia, L., & Francque, S. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i15.1905 · Cited by 27
Paris, T., George, E. S., Roberts, S. K., & Tierney, A. C. (2017) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000890 · Cited by 27
Pοlyzos, S. A., Kountouras, J., Zavos, C., Stergiopoulos, C., & Pοlyzos, S. A. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.12.028 · Cited by 26
Self-citationPοlyzos, S. A., Kountouras, J., & Zavos, C. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181b5ce68 · Cited by 22
Self-citationWeight reduction for non-alcoholic fatty liver disease
Peng, L., Wang, J., & Li, F. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003619.pub2 · Cited by 18
Khaleel, E. F., & Abdel‐Aleem, G. A. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1437638 · Cited by 15
Adiponectin is associated with poor prognosis in carcinoma patients: evidence from a meta-analysis
Ye, J., Liang, Z., Liang, Q., Zhang, J., Mao, S., & Liang, R. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0157-4 · Cited by 10
Research works printed but not linked: 3
- Polyzos, 2009, The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease, Hippokratia, 13, 127
- Kim, 2018, Non-alcoholic fatty liver disease in obese and non-obese pediatric patients, Korean J Pediatr
- Cotler, 2004, Hepatic decompensation after gastric bypass surgery for severe obesity, Dig Dis Sci, 49, 1563, 10.1023/B:DDAS.0000043364.75898.c8 · doi:10.1023/b:ddas.0000043364.75898.c8
Cited by
Non-alcoholic fatty liver disease
Powell, E. E., Wong, V. W.-S., & Rinella, M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32511-3 · Cited by 2,789
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Quek, J., Chan, K. E., Wong, Z. Y., Tan, C., Tan, B., Lim, W. H., Tan, D. J. H., Tang, A. S. P., Tay, P., Xiao, J., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00317-x · Cited by 749
NAFLD as a Continuum: From Obesity to Metabolic Syndrome and Diabetes
Godoy-Matos, A. F., Silva Júnior, W. S., & Valerio, C. M. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00570-y · Cited by 643
“Treating obesity in patients with NAFLD Excess body weight is an important cornerstone of NAFLD’s pathophysiology, and it is also a critical determinant of adverse clinical outcomes [76].”
BackgroundKanwal, F., Shubrook, J. H., Adams, L. A., Pfotenhauer, K., Wai-Sun Wong, V., Wright, E., Abdelmalek, M. F., Harrison, S. A., Loomba, R., Mantzoros, C. S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.049 · Cited by 618
Self-citation
Metadata
- Authors
- Polyzos, S. A., Kountouras, J., & Mantzoros, C. S.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 92
- Pages
- 82-97
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2902419609
- Cited by
- 1,211
- References
- 219
- FWCI
- 46.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.